Fig. 7
From: SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
Virtual screening results between SNAP-25 and FDA-approved drugs. A Structure of the rat neuronal SNARE complex (PDB accession#: 3HD7[22] and binding pocket predicted by PROTEINS PLUS (https://proteins.plus/). B H-bond receptor surface between SNAP-25 and Pazopanib. C Residues of interaction between Pazopanib and SNAP-25. The other corrected information of virtual screening is shown in Table 2